-
Harpadon Peptides Protect Against Angiotensin II Injury
2026-09-29
This ACS Omega study identified two peptides from Harpadon nehereus bone collagen, KA-8 and PG-7, that reduced Angiotensin II-induced oxidative injury and endothelial dysfunction in HUVECs. PG-7 showed the stronger activity and was associated with Nrf2 activation, PI3K/AKT/eNOS signaling, reduced endothelin-1, and ACE inhibition, providing a mechanistic basis for further antihypertensive research.
-
8-Chloroadenosine in lncRNA-Driven NSCLC Research
2026-09-29
A translational framework for using 8-Chloroadenosine to distinguish transcriptional control from RNA decay in the RP3-340N1.2–ZC3H12A–IL-6 axis of non-small cell lung cancer research.
-
Ampicillin Sodium: Assays, Workflows & Troubleshooting
2026-09-28
Build a reproducible ampicillin susceptibility workflow around a clear mechanism, controlled broth dilution, and practical checks for stock and inoculum quality. The article distinguishes product benchmarks from strain-specific results and shows how comparative β-lactam research can guide assay design without overinterpreting resistance data.
-
Phosphorylation Fidelity in cGAS Signal Research
2026-09-27
A 2026 study reveals how RSK3 and β-TRCP1 regulate OTUD3 stability and cGAS activation. This article translates that mechanism into practical sample-preparation guidance, including where a two-component phosphatase inhibitor can support phosphorylation measurements—and where experimental caution is essential.
-
TPCA-1 for NF-κB and Cell-Death Assays
2026-09-26
Use TPCA-1 to separate IKK-2-dependent inflammatory transcription from RIPK1-regulated cell-death responses in carefully controlled experiments. The workflow combines cytokine and pathway readouts with practical formulation, dosing, and troubleshooting guidance.
-
Amikacin (BAY416651): Research Profile
2026-09-26
Amikacin (BAY416651) is a semi-synthetic aminoglycoside antibiotic and bacterial protein synthesis inhibitor for laboratory research. A 2025 study of carbapenem-resistant Enterobacter cloacae documents frequent carbapenemase genes and gene transfer, but its gentamicin findings do not establish amikacin susceptibility.
-
Deferoxamine mesylate in Iron-Stress Assays
2026-09-25
Use Deferoxamine mesylate as a tunable iron-chelation control to investigate labile iron, oxidative injury, and hypoxia signaling—not as a stand-in for a multifunctional nanomaterial. This workflow connects recent acute kidney injury research to practical cell-assay design, with dose-selection and troubleshooting guidance for reproducible results.
-
S63845 at the Apoptosis-Ferroptosis Boundary
2026-09-25
S63845 is a potent MCL1 inhibitor for studying mitochondrial apoptosis in cancer models. This article examines how ferroptotic stress can alter cell-death readouts, helping researchers distinguish pathway activation from a change in death modality.
-
Acetylspiramycin: From Ribosome to Translational Evidence
2026-09-24
Acetylspiramycin (Spiramycin B) offers translational researchers a way to interrogate macrolide activity through both bacterial ribosome biology and carefully bounded host-response questions. This article connects mechanism to assay design, resistance interpretation, and a cautionary ocular case—without treating evidence from different biological domains as interchangeable.
-
Separating Growth Arrest from Cell Death in Cancer Assays
2026-09-24
Hannah R. Schwartz’s dissertation highlights a fundamental issue in cancer drug testing: relative viability and fractional viability describe different parts of a response and should not be treated as interchangeable. Its findings support measuring growth inhibition and cell killing separately, then interpreting their magnitude and timing together when evaluating anticancer compounds.
-
V5 Epitope Tag Peptide: Workflow Guide
2026-09-23
Turn the V5 tag into a practical control for recombinant protein detection, immunoprecipitation, localization, and antibody screening. This workflow combines high-purity peptide handling with assay-specific controls and the fast-dissociation antibody strategy reported for advanced single-molecule imaging.
-
Adamtsl3, MMP9, and Perineuronal Net Plasticity
2026-09-23
This study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal net integrity in parvalbumin-positive interneurons. Through mouse genetics, imaging, biochemical analysis, and pharmacological rescue, the authors connect Adamtsl3 loss to elevated MMP9 activity, impaired Otx2 uptake, oxidative stress, and renewed adult cortical plasticity.
-
PNU 74654: Wnt Signaling Workflow Guide
2026-09-22
PNU 74654 is a DMSO-soluble small molecule tool for controlled Wnt/β-catenin signaling inhibition in cancer research, stem cell research, and progenitor-fate assays. This practical guide connects pathway readouts with the fibro/adipogenic progenitor findings of a landmark muscle study while emphasizing dose design, controls, and troubleshooting.
-
Carboplatin Assay Workflows for Cancer Research
2026-09-21
Build more reproducible Carboplatin dose–response, DNA-damage, and combination studies with practical handling guidance for ovarian and lung cancer models. This workflow emphasizes model-specific sensitivity, comparator-controlled designs, and troubleshooting for solubility, assay timing, and apparent drug interactions.
-
Pazopanib (GW-786034) in ATRX-Deficient Models
2026-09-21
Build reproducible glioma, endothelial, and combination assays around Pazopanib’s multi-target RTK activity. This workflow connects ATRX genotype, VEGF signaling pathway readouts, and dose-response design while separating tumor-cell effects from angiogenesis inhibition.